Telomere maintenance and tumorigenesis: An "ALT"ernative road

Current Molecular Medicine

Volumn 5, Issue 2, 2005, Pages 253-257

  Stewart, Sheila A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTISENSE OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; PHOSPHOPROTEIN PHOSPHATASE; RAD50 PROTEIN; RAD52 PROTEIN; RIBOZYME; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 2;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER MODEL; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CELL DEATH; CELL IMMORTALIZATION; CELL ISOLATION; CELL TRANSFORMATION; CYTOTOXICITY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC RECOMBINATION; GENOMIC INSTABILITY; GLIOBLASTOMA; HUMAN; KNOCKOUT MOUSE; MESENCHYME CELL; MISMATCH REPAIR; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; RNA INTERFERENCE; SENESCENCE; TELOMERE; TRINUCLEOTIDE REPEAT; TUMOR CELL LINE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; TELOMERE;

EID: 18044370239     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566524053586653     Document Type: Review

References (59)

1. Hahn, W.C., et al., (1999) Nature, 400, p. 464-468.
2. Hahn, W.C., et al., (2002) Mol. Cell Biol., 22 (7), pp. 2111-23.
3. Harley, C.B., Futcher, A.B. and Greider, C.W. (1990) Nature, 345(6274), pp. 458-460.
4. Shay, J.W., Wright, W.E. and Werbin, H. (1991) Biochim. Biophys. Acta, 1072(1), pp. 1-7.
5. Blackburn, E.H. (1991) Nature, 350(6319), pp. 569-573.
6. Greider, C.W. and Blackburn, E.H. (1996) Sci. Am., 274(2), pp. 92-97.
7. McClintock, B. (1941) Genetics, 26, pp. 234-282.
8. Blackburn, E.H. (2000) Nature, 408(6808), pp. 53-6.
9. de Lange, T. (2002) Oncogene, 21(4), pp. 532-40.
10. d' Adda di Fagagna, F., et al., (2003) Nature, 426(6963), pp. 194-8.
11. d'Adda di Fagagna, F., Teo, S.H. and Jackson, S.P. (2004) Genes. Dev., 18(15), pp. 1781-99.
12. Campisi, J. (1996) Cell, 84, pp. 497-500.
13. Bodnar, A.G., et al., (1998) Science, 279 (5349), pp. 349-52.
14. Vaziri, H. and Benchimol, S. (1998) Curr. Biol., 8 (5), pp. 279-82.
15. Zhang, X., et al., (1999) Gene. Dev., 13, pp. 2388-2399.
16. Hahn, W.C., et al., (1999) Nat. Med., 5 (10), pp. 1164-70.
17. Shay, J.W. and Bacchetti, S. (1997) Eur. J. Cancer, 33, pp. 787-791.
18. Bryan, T.M., et al., (1995) EMBO J., 14 (17), pp. 4240-4248.
19. Elayadi, A.N., et al., (2001) Nucl. Acids Res., 29(8), pp. 1683-9.
20. Feng, J., et al., (1995) Science, 269 (5228), pp. 1236-41.
21. Hamilton, S.E., et al., (1999) Chem. Biol., 6 (6), pp. 343-51.
22. Norton, J.C., et al., (1996) Nat. Biotechnol., 14(5), pp. 615-9.
23. Tamura, Y., et al., (2000) Antisense Nucleic Acid Drug Dev., 10(2), pp. 87-96.
24. Herbert, B., et al., (1999) Proc. Natl. Acad. Sci. USA, 96(25), pp. 14276-81.
25. Ludwig, A., et al., (2001) Cancer Res., 61 (7), pp. 3053-61.
26. Folini, M., et al., (2000) J. Invest. Dermatol., 114(2), pp. 259-67.
27. Meyerson, M., et al., (1997) Cell, 90, pp. 785-795.
28. Nakamura, T.M., et al., (1997) Science, 277 (5328), pp. 955-9.
29. Vonderheide, R.H., et al., (2004) Clin. Cancer Res., 10(3), pp. 828-39.
30. Minev, B., et al., (2000) Proc. Natl. Acad. Sci. USA, 97(9), pp. 4796-801.
31. Nair, S.K., et al., (2000) Nat. Med., 6(9), pp. 1011-7.
32. Vonderheide, R.H., et al., (2001) Clin. Cancer Res., 7(11), pp. 3343-8.
33. Vonderheide, R.H., et al., (2001) Cancer Res., 61(23), pp. 8366-70.
34. Bryan, T.M., et al., (1997) Nat. Med., 3 (11), pp. 1271-4.
35. Ulaner, G.A., et al., (2003) Cancer Res., 63 (8), pp. 1759-63.
36. Hakin-Smith, V., et al., (2003) Lancet, 361 (9360), pp. 836-8.
37. Stewart, S.A., et al., (2002) In press.
38. Chang, S., et al., (2003) Genes. Dev., 17 (1), pp. 88-100.
39. Wang, R.C., Smogorzewska, A. and de Lange, T. (2004) Cell 119(3), pp. 355-68.
40. Griffith, J. D., et al., (1999) Cell, 97 (4), pp. 503-514.
41. Smogorzewska, A., et al., (2002) Curr. Biol., 12(19), pp. 1635-44.
42. Liu, Y., et al., (2004) Science, 303(5655), pp. 243-6.
43. Cesare, A.J. and Griffith, J.D. (2004) Mol. Cell Biol., 24(22), pp. 9948-57.
44. Tokutake, Y., et al., (1998) Biochem. Biophys. Res. Commun., 247(3), pp. 765-72.
45. Dunham, M.A., et al., (2000) Nat. Genet., 26 (4), pp. 447-50.
46. Bechter, O.E., et al., (2003) EMBO Rep., 4 (12), pp. 1138-43.
47. Mumane, J.P., et al., (1994) EMBO J., 13 (20), pp. 4953-62.
48. Perrem, K., et al., (2001) Mol. Cell Biol., 21 (12), pp. 3862-75.
49. Bucholc, M., Park, Y. and Lustig, A.J. (2001) Mol. Cell Biol., 21(19), pp. 6559-73.
50. Lundblad, V. and Blackburn, E.H. (1993) Cell, 73 (2), pp. 347-60.
51. Lundblad, V. (2002) Oncogene, 21(4), pp. 522-31.
52. Lundblad, V. and Szostak, J.W. (1989) Cell, 57 (4), pp. 633-43.
53. Lendvay, T.S., et al., (1996) Genetics, 144 (4), pp. 1399-412.
54. Johnson, F.B., et al., (2001) EMBO J., 20 (4), pp. 905-13.
55. Le, S., et al., (1999) Genetics, 152(1), pp. 143-52.
56. Chen, Q., Ijpma, A. and Greider, C.W. (2001) Mol. Cell Biol., 21(5), pp. 1819-27.
57. Blasco, M.A., et al., (1997) Cell, 91(1), pp. 25-34.
58. Bechter, O. E., et al., (2004) Cancer Res., 64 (10), pp. 3444-51.
59. Rizki, A. and Lundblad, V. (2001) Nature, 411 (6838), pp. 713-6.